Angiotensin Converting Enzyme (ACE) Activity in Porcine Ocular Tissue: Effects of Diet and ACE Inhibitors

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 6, 2003, Pages 589-598

  Geng, Lijun ^a   Persson, Karin ^a   Nilsson, Siv F E ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ANGIOTENSIN I; ENALAPRIL;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL DIET; CHOROID; CILIARY BODY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EYE; FEMALE; IRIS; NONHUMAN; RADIOENZYMATIC ASSAY; RETINA; SWINE; TISSUE HOMOGENATE; ANIMAL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MINIPIG; TIME; UVEA;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, ABDOMINAL; CAPTOPRIL; DIET, ATHEROGENIC; ENALAPRIL; FEMALE; PEPTIDYL-DIPEPTIDASE A; RETINA; SWINE; SWINE, MINIATURE; TIME FACTORS; UVEA;

EID: 0347993812     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803322660503     Document Type: Article

References (39)

1. Dzau, V.J., Bernstein, K., Celermajer, D., Cohen, J., Dahlöf, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., Van Gilst, W., Hansson, L., Hornig, B., Husain, A., Johnston, C., Lazar, H., Lonn, E., Luscher, T., Mancini, J., Mimran, A., Pepine, C., Rabelink, T., Remme, W., Ruilope, L., Ruzicka, M., Schunkert, H., Swedberg, K., Unger, T., Vaughan, D., and Weber, M. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc. Drugs Ther. 16:149-160, 2002.
2. Diet, F., Pratt, R.E., Berry, G.J., Momose, N., Gibbons, G.H., and Dzau, V.J. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767, 1996.
3. Miyazaki, M., Sakonjo, H., and Takai, S. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet. Br. J. Pharmacol. 128:523-529, 1999.
4. Hoshida, S., Nishida, M., Yamashita, N., Igarashi, J., Aoki, K., Hori, M., Kuzuya, T., and Tada, M. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril. Atherosclerosis 130:53-59, 1997.
5. Mitani, H., Bandoh, T., Kimura, M., Totsuka, T., and Hayashi, S. Increased activity of vascular ACE related to atherosclerotic lesions in hyperlipidemic rabbits. Am. J. Physiol. 271:H1065-H1071, 1996.
6. Persson, K. Pharmacological interactions between angiotensin-converting enzyme (ACE) inhibitors, bradykinin and nitric oxide. Linköping University Medical Dissertation, 630:1-105, 2000.
7. Jacobsson, L.S., Persson, K., Aberg, G., Andersson, R.G., Karlberg, B.E., and Olsson, A.G. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J. Cardiovasc. Pharmacol. 24:670-677, 1994.
8. Li, J., Hirose, N., Kawamura, M., and Arai, Y. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits. Atherosclerosis 143:315-326, 1999.
9. Kowala, M.C., Recce, R., Beyer, S., and Aberg, G. Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril. J. Cardiovasc. Pharmacol. 25:179-186, 1995.
10. Ramirez, M., Davidson, E.A., Luttenauer, L., Elena, P.P., Cumin, F., Mathis, G.A., and De Gasparo, M. The renin-angiotensin system in the rabbit eye. J. Ocul. Pharmacol. Ther. 12:299-312, 1996.
11. Ferrari-Dileo, G., Ryan, J.W., Rockwood, E.J., Davis, E.B., and Anderson D. R. Angiotensin-converting enzyme in bovine, feline, and human ocular tissues. Invest. Ophthalmol. Vis. Sci. 29:876-81, 1988.
12. Danser, A.H., Derkx, F.H., Admiraal, P.J., Deinum, J., de Jong, P.T., and Schalekamp, M.A. Angiotensin levels in the eye. Invest. Ophthalmol. Vis. Sci. 35:1008-1018, 1994.
13. Wheeler-Schilling, T.H., Sautter, M., Guenther, E., and Kohler, K. Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina. Exp. Eye Res. 72:173-182, 2001.
14. Shiota, N., Saegusa, Y., Nishimura, K., and Miyazaki, M. Angiotensin II-generating system in dog and monkey ocular tissues. Clin. Exp. Pharmacol. Physiol. 24:243-248, 1997.
15. Kohler, K., Wheeler-Schilling, T., Jurklies, B., Guenther, E., and Zrenner, E. Angiotensin II in the rabbit retina. Vis. Neurosci. 14:63-71, 1997.
16. Wagner, J., Jan Danser, A.H., Derkx, F.H., de Jong, T.V., Paul, M., Mullins, J.J., Schalekamp, M.A., and Ganten, D. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br. J. Ophthalmol. 80:159-163, 1996.
17. Nyborg, N.C., Nielsen, P.J., Prieto, D., and Benedito, S. Angiotensin II does not contract bovine retinal resistance arteries in vitro. Exp. Eye Res. 50:469-474, 1990.
18. Meyer, P., Flammer, J., and Luscher, T.F. Local action of the rennin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists. Invest. Ophthalmol. Vis. Sci. 366:555-562, 1995.
19. Nyborg, N.C., and Nielsen, P.J. Angiotensin-II contracts isolated human posterior ciliary arteries. Invest. Ophthalmol. Vis. Sci. 31:2471-24-73, 1990.
20. Rockwood, E.J., Fantes, F., Davis, E.B., and Anderson, D.R. The response of retinal vasculature to angiotensin. Invest. Ophthalmol. Vis. Sci. 28:676-682, 1987.
21. Krejcy, K., Wolzt, M., Kreuzer, C., Breteneder, H., Schultz, W., Eichler, H.G., and Schmetterer, L. Characterization of angiotensin-II effects on cerebral and ocular circulation by noninvasive methods. Br. J. Clin. Pharmacol. 43:501-508, 1997.
22. Matulla, B., Streit, G., Pieh, S., Findl, O., Entlicher, J., Graselli, U., Eichler, H.G., Wolst, M., and Schmetterer, L. Effects of losartan on cerebral and ocular circulation in healthy subjects. Br. J. Clin. Pharmacol. 44:369-375, 1997.
23. Campell, D.J. Vasopeptidase inhibition: a double-edged Sword? Hypertension 41:383-389, 2003.
24. Lundholm, L., Jacobsson, L., Brattsand, R., and Magnusson, O. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs. Atherosclerosis 29:217-239, 1978.
25. Neels, H.M., Scharpe, S.L., van Sande, M.E., Verkerk, R.M., and Van Acker, K.J. Improved micromethod for assay of serum angiotensin converting enzyme. Clin. Chem. 28:1352-1355, 1982.
26. Hayreh, S.S. Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Prog. Retin. Eye Res. 18:191-221, 1999.
27. Friedman, E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am. J. Ophthalmol. 130:658-663, 2000.
28. Halkin, A., and Keren, G. Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease. Am. J. Med. 112:126-134, 2002.
29. Schiffrin, E.L. Vascular and cardiac benefits of angiotensin receptor blockers. Am. J. Med. 113:409-418, 2002.
30. Rakugi, H., Wang, D.S., Dzau, V.J., and Pratt, R.E. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 90:449-455, 1994.
31. Wollert, K.C., Studer, R., von Bulow, B., and Drexler, H. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition. Circulation 90:2457-2467, 1994.
32. Wilkinson-Berka, J.L., Kelly, D.J., and Gilbert, R.E. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes. J. Vasc. Res. 38:527-535, 2001.
33. Sjolie, A.K., and Chaturvedi, N. The renin-angiotensin system: implications for therapy in diabetic retinopathy. J. Hum. Hypertens. 16(Suppl. 3):S42-S46, 2002.
34. Moravski, C.J., Kelly, D.J., Gilbert, R.E., Cooper, M.E., Gilbert, R.E., Bertram, J.F., Shahinfar, S., Skinner, S.L., and Wilkinson-Berka, J.L. Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 36:1099-1104, 2000.
35. Costagliola, C., Di Benedetto, R., De Caprio, L., Verde, R., and Mastropasqua, L. Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur. J. Ophthalmol. 5:19-25, 1995.
36. Constad, W.H., Fiore, P., Samson, C., and Cinotti, A.A. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am. J. Ophthalmol. 105:674-677, 1988.
37. Nishiyama, A., Seth, D.M., and Navar, L.G. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39:129-134, 2002.
38. Fox, J., Guan, S., Hymel, A.A., and Navar, L.G. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am. J. Physiol. 262:F902-F909, 1992.
39. Ackermann, A., Fernandez-Alfonso, M.S., Sanchez de Rojas, R., Ortega, T., Paul, M., and Gonzalez, C. Modulation of angiotensin-converting enzyme by nitric oxide. Br. J. Pharmacol. 124:291-298, 1998.